文献速递肝胆胰外科围术期管理与 ERAS

机器人单孔与多孔腹腔镜胆囊切除术的短期和长期成本病例匹配分析

Robotic single-site versus multiport laparoscopic cholecystectomy: a case-matched analysis of short- and long-term costs.
PubMed 文献 · Surg Endosc · 2017-10-19

该研究将2011至2015年间因良性非炎性疾病行机器人单孔胆囊切除术的99例患者与99例多孔腹腔镜胆囊切除术患者进行病例匹配,比较围术期和长期成本。结果显示机器人单孔组围术期成本显著更高(6158.0 vs. 4288.0 USD,p<0.0001),随访手术率更高(7.1 vs. 0.0%,p=0.0140),随访成本也显著更高(694.7 vs. 0.0 USD,p=0.0145),而早期临床结果相似。

要点

  • 机器人单孔胆囊切除术围术期成本显著高于多孔腹腔镜(6158.0 vs. 4288.0 USD)。
  • 机器人单孔组随访手术率更高(7.1 vs. 0.0%),随访成本更高(694.7 vs. 0.0 USD)。
  • 两组早期术后临床结果相似,但机器人单孔组门诊手术比例更高(31.3 vs. 17.2%)。

核心结论

  • 机器人单孔胆囊切除术的围术期和长期成本均显著高于多孔腹腔镜胆囊切除术,且再手术率更高,而早期临床结果相似。

研究设计与样本

  • 回顾性病例匹配分析,将2011至2015年间99例机器人单孔胆囊切除术患者与99例多孔腹腔镜胆囊切除术患者按疾病、年龄、性别、BMI、ASA分级、诊断和手术年份进行匹配。

主要发现

  • 机器人单孔组门诊手术比例更高(31.3 vs. 17.2%,p=0.0305),人口学参数和围术期临床结果相似。
  • 机器人单孔组围术期成本显著更高(6158.0 vs. 4288.0 USD,p<0.0001)。
  • 两组随访时间相似(59.0 vs. 58.9个月,p=0.9552),但机器人单孔组随访手术率更高(7.1 vs. 0.0%,p=0.0140),随访成本更高(694.7 vs. 0.0 USD,p=0.0145)。

临床怎么用

  • 在考虑采用机器人单孔胆囊切除术时,需权衡其显著更高的短期和长期成本及再手术率,与多孔腹腔镜金标准相比临床价值尚不明确。

局限性

  • 回顾性研究设计,样本量有限(每组99例),随访至2017年2月,可能受选择偏倚影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multiport laparoscopy is the gold-standard approach for cholecystectomy, and single-port laparoscopy has been developed to further reduce its invasiveness. A specific robotic single-port platform (da Vinci single-site, Intuitive Surgical Inc., Sunnyvale, CA, USA) has been released in 2011, which could technically facilitate single-site cholecystectomy. Current data show its feasibility; however, detailed short- and long-term analyses of costs and comparisons relative to multiport laparoscopy are not available to date. METHODS: Patients who underwent robotic single-site cholecystectomy for benign, clinically noninflammatory disease between 2011 and 2015 were matched for disease, age, gender, BMI, ASA classification, diagnosis, and elapsed year of surgery to a cohort of multiport cholecystectomies. Demographic, perioperative, and long-term data were collected retrospectively and analyzed. Perioperative and long-term costs including re-operations due to the primary procedure until February 2017 were compared across both cohorts. RESULTS: 99 patients who underwent robotic single-site cholecystectomy were matched to 99 patients with multiport cholecystectomy. A higher rate of outpatient procedures in the robotic cohort (31.3 vs. 17.2%, p = 0.0305) was found, and demographic parameters and perioperative clinical outcomes were similar. Perioperative costs were significantly higher for the robotic single-site patients (6158.0 vs. 4288.0 USD, p < 0.0001). With similar follow-up times of 59.0 and 58.9 months, respectively (p = 0.9552), significantly more patients of the robotic Single-Site cohort underwent follow-up surgery (7.1 vs. 0.0%, p = 0.0140), and follow-up costs were significantly higher for the robotic cohort (694.7 vs. 0.0 USD, p = 0.0145). CONCLUSION: With similar early postoperative clinical results and a higher rate of re-operations, perioperative and long-term costs are significantly higher with robotic Single-Site cholecystectomy compared with multiport cholecystectomy. Considering the unclear clinical value of robotic single-site cholecystectomy and the significant short- and long-term costs, a call for further research and a debate as to who should bear the costs beyond the ones of the gold-standard treatment appear reasonable.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Hagen ME, Balaphas A, Podetta M, et al. Robotic single-site versus multiport laparoscopic cholecystectomy: a case-matched analysis of short- and long-term costs. Surg Endosc. 2017. PMID: 29052069. doi:10.1007/s00464-017-5843-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。